David A. Siegel Natera, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Natera, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 315,300 shares of NTRA stock, worth $52.7 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
315,300
Previous 225,400
39.88%
Holding current value
$52.7 Million
Previous $24.4 Million
64.18%
% of portfolio
0.1%
Previous 0.06%
Shares
24 transactions
Others Institutions Holding NTRA
# of Institutions
526Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.91 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.13 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$775 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$762 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$671 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.2B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...